Castle Biosciences, Inc. (CSTL)

Castle Biosciences Stock Forecast

Stock Price Forecast

The 6 analysts that cover Castle Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $42.83, which forecasts a 8.72% increase in the stock price over the next year. The lowest target is $35 and the highest is $50.

Price Target: $42.83 (+8.72%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$35	$42.83	$41	$50
Change	-11.16%	+8.72%	+4.07%	+26.92%

Analyst Ratings

The average analyst rating for Castle Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	2	2	2	3	3
Buy	4	4	4	4	4	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	7	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kyle Mikson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $37 → $50	Strong Buy	Maintains	$37 → $50	+26.92%	Dec 22, 2025
Mark Massaro BTIG	BTIG	Strong Buy Maintains $38 → $50	Strong Buy	Maintains	$38 → $50	+26.92%	Dec 12, 2025
Mark Massaro BTIG	BTIG	Strong Buy Maintains $32 → $38	Strong Buy	Maintains	$32 → $38	-3.54%	Nov 5, 2025
Catherine Ramsey Baird	Baird	Buy Maintains $39 → $41	Buy	Maintains	$39 → $41	+4.07%	Nov 4, 2025
Kyle Mikson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $37	Strong Buy	Maintains	$37	-6.08%	Sep 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

337.68M

Increased by 1.69%

from 332.07M

Revenue Next Year

334.63M

Decreased by -0.90%

from 337.68M

EPS This Year

-1.15

from 0.62

EPS Next Year

-1.45

from -1.15

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	62.65M	94.09M	137.04M	219.79M	332.07M	337.68M	334.63M
Revenue Growth	20.79%	50.18%	45.65%	60.38%	51.09%	1.69%	-0.90%
EPS	-0.54	-1.24	-2.58	-2.14	0.62	-1.15	-1.45
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	351.0M	349.7M
Avg	337.7M	334.6M
Low	311.6M	313.3M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	5.7%	3.5%
Avg	1.7%	-0.9%
Low	-6.2%	-7.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-1.11	-1.07
Avg	-1.15	-1.45
Low	-1.20	-2.01

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.